A multispecific antigen-binding molecule having cofactor function substitution activity for blood clotting factor VIII (FVIII), and a pharmaceutical formulation containing said molecule as the active ingredient.
MA50667AUndetermined Publication Date: 2020-08-05CHUGAI PHARMA CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA50667
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2017-09-29
- Filing Date
- 2018-09-27
- Publication Date
- 2020-08-05
Need to check novelty before this filing date? Find Prior Art
No text content released.